Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: RevMed is seeking an experienced Senior Corporate Paralegal to support the Company’s public company reporting and corporate governance functions. This role will play a critical part in managing SEC reporting processes, Board and committee governance operations, securities law compliance administration, and entity management activities. The Senior Corporate Paralegal will report to the Senior Director, Corporate Disclosure & Governance and will work closely with Legal, Finance, Investor Relations, and external advisors. The ideal candidate brings deep public company experience, strong drafting and document management skills, and the ability to operate effectively in a fast-paced, highly regulated environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
251-500 employees